Javascript must be enabled to continue!
Advanced Physiotherapy Intervention for Muscular Dystrophy
View through CrossRef
Muscular dystrophies are rare neuromuscular conditions which are genetically and clinically diverse that cause gradual, progressive weakness and breakdown of skeletal muscles over time. Gene mutations, typically in those involved in producing muscle proteins, are the primary cause of muscular dystrophy. Based on these gene mutations and proteins involved a wide variety of muscular dystrophies have been identified. The primary muscles affected, the level of weakness, the rate at which symptoms increase, and the onset of symptoms vary among different muscular dystrophies. Some forms are linked to issues with other organ systems. The kind of muscular dystrophy will be ascertained through a physical examination, medical history, and other diagnostic techniques. Currently, there is no cure for muscular dystrophy. Multidisciplinary management plays a vital role in increasing life expectancy and improving the quality of life. Physical therapy as a part of supportive care management can help muscular dystrophy patients in various ways. It can help in maintaining joint range of motion, flexibility, and overall fitness. It helps in maintaining muscle strength, improving range of motion, and reducing pain. In this chapter, we will present the advanced physiotherapeutic interventions helpful for subjects with muscular dystrophies, based on the evidence available in the literature.
Title: Advanced Physiotherapy Intervention for Muscular Dystrophy
Description:
Muscular dystrophies are rare neuromuscular conditions which are genetically and clinically diverse that cause gradual, progressive weakness and breakdown of skeletal muscles over time.
Gene mutations, typically in those involved in producing muscle proteins, are the primary cause of muscular dystrophy.
Based on these gene mutations and proteins involved a wide variety of muscular dystrophies have been identified.
The primary muscles affected, the level of weakness, the rate at which symptoms increase, and the onset of symptoms vary among different muscular dystrophies.
Some forms are linked to issues with other organ systems.
The kind of muscular dystrophy will be ascertained through a physical examination, medical history, and other diagnostic techniques.
Currently, there is no cure for muscular dystrophy.
Multidisciplinary management plays a vital role in increasing life expectancy and improving the quality of life.
Physical therapy as a part of supportive care management can help muscular dystrophy patients in various ways.
It can help in maintaining joint range of motion, flexibility, and overall fitness.
It helps in maintaining muscle strength, improving range of motion, and reducing pain.
In this chapter, we will present the advanced physiotherapeutic interventions helpful for subjects with muscular dystrophies, based on the evidence available in the literature.
Related Results
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Abstract
Background
Neurogenic thoracic outlet syndrome (nTOS) is the most prevalent subtype of thoracic outlet syndrome and remains one of the most controversial conditions in per...
Clinico-pathological Diagnosis of Facioscapulohumeral Dystrophy in a 22-year-old Male
Clinico-pathological Diagnosis of Facioscapulohumeral Dystrophy in a 22-year-old Male
Background: Facioscapulohumeral dystrophy (FSHD) is a rare hereditary disease with a prevalence of 2.03–6.8 per 100,000 individuals. FSHD is the third most common type of muscular ...
Duchene’s muscular dystrophy: a clinical case
Duchene’s muscular dystrophy: a clinical case
Background. Muscular dystrophy is a heterogeneous group of genetic disorders characterized by progressive loss of skeletal muscles. Duchene's muscular dystrophy (MDD) is one of the...
An Automated Identification of Muscular Atrophy and Muscular Dystrophy Disease in Fetus using Deep Learning Approach
An Automated Identification of Muscular Atrophy and Muscular Dystrophy Disease in Fetus using Deep Learning Approach
Muscular Atrophy (MA) and Muscular dystrophy (MD) diseases are genetic diseases. These diseases are commonly diagnosed with the help of techniques such as chorionic villus sampling...
Advancing Cardiorespiratory Physiotherapy Practice in a Developing Country: Surveying and Benchmarking
Advancing Cardiorespiratory Physiotherapy Practice in a Developing Country: Surveying and Benchmarking
Management of noncommunicable diseases requires the adoption of multidisciplinary interventions that targets the modification of risk factors. Cardiovascular and respiratory diseas...
A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
Abstract
A novel canine muscular dystrophy in Landseer dogs was observed. We had access to five affected dogs from two litters. The clinical signs started at a few w...
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease; it occurs due to a mutation in the dystrophin protein gene; as a result, the protein is not synthesized an...
The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
It is well known that muscular dystrophy disease severity is controlled by genetic modifiers. The expectation is that by identifying these modifiers, we can illuminate additional t...

